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Adipocytes promote progression of multiple cancers, but their role in pancreatic intraepithelial neoplasia
(PanIN) and ductal adenocarcinoma (PDAC) is poorly deﬁned. Nutrient transfer is a mechanism underlying
stromal cell-cancer crosstalk. We studied the role of adipocytes in regulating in vitro PanIN and PDAC cell
proliferation with a focus on glutamine metabolism. Murine 3T3L1 adipocytes were used to model adi-
pocytes. Cell lines derived from PKCY mice were used to model PanIN and PDAC. Co-culture was used to
study the effect of adipocytes on PanIN and PDAC cell proliferation in response to manipulation of glu-
tamine metabolism. Glutamine secretion was measured with a bioanalyzer. Western blotting was used to
study the effect of PanIN and PDAC cells on expression of glutamine-related enzymes in adipocytes. Adi-
pocytes promote proliferation of PanIN and PDAC cells, an effect that was ampliﬁed in nutrient-poor
conditions. Adipocytes secrete glutamine and rescue PanIN and PDAC cell proliferation in the absence of
glutamine, an effect that was glutamine synthetase-dependent and involved PDAC cell-induced down-
regulation of glutaminase expression in adipocytes. These ﬁndings suggest glutamine transfer as a po-
tential mechanism underlying adipocyte-induced PanIN and PDAC cell proliferation.
Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Stromal cell-tumor crosstalk contributes to carcinogenesis.
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.edu (A.D. Rhim),ﬁbroblasts, but a growing literature implicates adipocytes. Peri-
tumor adipocytes predict poor prognosis in multiple cancers [1,2],
and adipocytes promote proliferation and invasion of multiple
types of cancer cells in in vitro and in vivo models [3–10]. Similar
data support a role for adipocytes in PDAC: pancreatic steatosis in
humans predisposes to PanIN, PDAC, and to more advanced dis-
ease [11,12], while human adipose tissue stem cells promote
pancreatic cell proliferation and invasion in vitro [13]. Finally,
pancreatic adipocytes are associated with PDAC progression in
murine models [14–16].
The mechanisms by which adipocytes promote cancer are un-
known. An important candidate mechanism is reciprocal meta-
bolic programming that promotes energy transfer from stromal
cells to cancer cells. Such metabolic crosstalk has been demon-
strated in ﬁbroblast-tumor lactate shuttling in breast and prostate
cancers [17,18], while reciprocal changes in lipolysis and fatty acid
oxidation promote fatty acid delivery from adipocytes to ovarian
cancer [8].-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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undergoes metabolic reprogramming towards a non-canonical
glutamine catabolic pathway to produce NADPH for reducing ca-
pacity [19]. Transfer of glutamine from cancer-associated ﬁbro-
blasts to breast cancer cells drives breast cancer cell proliferation,
with reciprocal metabolic reprogramming that promotes gluta-
mine synthesis in ﬁbroblasts and glutamine catabolism in breast
cancer cells [20]. A single report implicates adipocytes as a source
of glutamine for cancer cells in the context of leukemia, with re-
ciprocal induction of glutamine synthetase (GS) in adipocytes that
promotes glutamine transfer to leukemia cells [21]. The speciﬁc
effects of adipocytes on PDAC cells in vitro are poorly deﬁned, and
whether adipocytes provide glutamine to PDAC is unknown. The
goal of this study was to deﬁne the effects of adipocytes on PanIN
and PDAC cell proliferation and determine if adipocytes inﬂuence
PanIN and PDAC cell proliferation via glutamine-dependent me-
tabolic crosstalk, utilizing murine PanIN and PDAC cell lines and
the murine 3T3L1 adipocyte line.2. Methods
2.1. Cell culture
All cell culture was performed in standard tissue culture con-
ditions of 37 °C, 5% CO2. Mature 3T3L1 adipocytes were generated
by culturing 3T3L1 preadipocytes (American Type Culture Collec-
tion, Manassas, VA, USA) in DMEM, 10% FCS, 500 μM IBMX, 1 μg/
ml insulin, 0.25 μM dexamethasone, 2 μM rosiglitazone for 3 days,
followed by culture in DMEM, 10%FCS, 1 μg/ml insulin for 3 days,
followed by culture in DMEM, 10% FCS for 7 days. Trypan Blue
staining was used to determine adipocyte viability.
Murine PI34 and PD7591 cell lines are derived from a PanIN
lesion (PI34) and a PDAC tumor (PD7591) from PKCY mice. The
PKCY strain contains a codon-12 K-ras gene mutation, present in
95% of human PDAC tumors and a ﬂoxed p53 allele, expression of
which is targeted to pancreatic epithelial cells via a Pdx1 pro-
moter-driven Cre-recombinase gene, thus generating a pancreas-
speciﬁc heterozygous p53 knockout on a mutant K-ras back-
ground. PKCY mice develop autochthonous PDAC by 18–20 weeks
of age with histopathologic progression similar to human disease
[22,23] Monoculture and co-culture experiments with mature
adipocytes, preadipocytes, and cancer cells were performed in
DMEM, 0.5% FCS with indicated glucose and glutamine con-
centrations. Conditioned media was generated by culturing ma-
ture adipocytes or PI34/PD7591 cells for 72 h in substrate condi-
tions matching the corresponding experiment, after which media
was harvested and used in a 50:50 mixture with fresh media
containing the same substrates as the conditioned media. The ir-
reversible glutamine synthetase inhibitor L-methionine sulfox-
imine (Sigma-Aldrich Inc., St. Louis MO, USA) was used at 10 mM
to pre-treat adipocytes for 24 h followed by thorough washing of
adipocytes 3 with PBS prior to their use in co-culture. The glu-
tamine exporter inhibitor L-glutamic acid γ-p-nitroanilide-hydro-
chloride (GPNA) (Sigma-Aldrich Inc.) was used at 1 mM and added
directly to co-culture media, given that its effect is not irreversible,
thus precluding pre-treatment of adipocytes prior to co-culture.
2.2. Oil Red-O staining
Differentiated adipocytes were washed with 500 μL 1X PBS,
then 200 μL 4% formalin was added and cells ﬁxed for 15 min, then
formalin was removed, and cells washed twice with 1X PBS, then
200 μL of 60% isopropanol added and cells incubated 5 min, then
isopropanol removed and 200 μL Oil Red-O solution (American
Master Tech Scientiﬁc Inc., Lodi, CA, USA) added, then cellsincubated 15 min, then Oil Red-O solution removed and cells
washed with 500 μL 1X PBS 3 times and imaged with light
microscopy.
2.3. QRTPCR
Equal amounts of input RNA prepared from cells using RNeasy
kit (Qiagen, Inc., Germantown, MD, USA) were used for quantita-
tive real-time polymerase chain reaction (QRTPCR). RNA was re-
verse-transcribed using a high capacity cDNA kit (Applied Bio-
systems, Inc., Foster City, CA, USA), and QRTPCR performed using
transcript-speciﬁc Taqman primer-probes using actin as an en-
dogenous control on an AB StepOnePlus Thermocycler (Applied
Biosystems, Inc., Foster City, CA, USA). The 2ddCT quantiﬁcation
method was used to calculate fold-difference in transcript levels.
The following murine-speciﬁc primer-probes were used (Ther-
moFisher Scientiﬁc Inc., Rockford, IL, USA): peroxisome pro-
liferator-activated receptor gamma (PPARg:Mm01184322_m1),
fatty acid synthase (FASN:Mm00662319_m1), adipose triglyceride
lipase (AGTL:Mm00503040_m1), sterol regulatory element-bind-
ing transcription factor 1c (SREBP1c, Mm00550338_m1), CCAAT/
Enhancer Binding Protein-alpha (CEBPa, Mm00514283_s1).
2.4. Western blotting
Adipocyte protein lysates in RIPA buffer (25–50 mg) underwent
7.5% SDS-PAGE gel electrophoresis, were transferred to PVDF mem-
brane, blocked in TBSTþ5%BSA for one hour at 25 °C, washed 3 times
in TBST, incubated in TBSTþ1%BSA overnight at 4 °C with primary
antibodies speciﬁc for glutamine synthetase (rabbit polyclonal,
1:5000, ThermoFisher Scientiﬁc Inc., Rockford, IL, USA, Cat#PA1-
46165), glutaminase (rabbit polyclonal, 1:1000, Abcam Inc., Cam-
bridge, MA, USA, Cat#ab93434), or glutamate dehydrogenase (rabbit
monoclonal, 1:1000, Abcam Inc., Cambridge, MA, USA, Cat#-
ab166618), then washed in TBST and incubated with IRDye800-
conjugated goat anti-rabbit IgG (1:10,000, Rockland Im-
munochemicals Inc., Gilbertsville, PA, USA, Cat#611-145-122) in
TBST/1%BSA for one hour at 25 °C. Parallel blots loaded with identical
amounts of the same lysates were probed with actin-speciﬁc primary
antibody (mouse monoclonal, 1:1000, ThermoFisher Scientiﬁc Inc.,
Rockford, IL, USA, Cat#MA5-15739) and Alexa Fluor 700-conjugated
secondary antibody (goat anti-mouse IgG, 1:1000, ThermoFisher
Scientiﬁc Inc., Rockford, IL, USA, Cat#A-20136). Densitometry was
performed using an Odyssey Infrared Imaging System and software
(LI-COR Biosciences Inc., Lincoln, NE, USA); densitometry signals for
glutamine synthetase, glutaminase, and glutamate dehydrogenase
were normalized to actin densitometry levels.
2.5. Proliferation assay
Semipermeable transwell membrane inserts (0.4 mm, Corning
Costar Inc., Tewksbury, MA, USA) containing 15,000 3T3L1 pre-
adipocytes or mature adipocytes were placed above 2000 PanIN/
PDAC cells in 24-well culture plates in 500 μl DMEM, 0.5%FCS with
glucose/glutamine concentrations as indicated, cultured 72 h,
transwells removed, and 50 μl XTT reagent (Biotium Inc., Hayward,
CA, USA) added, cells incubated overnight, then 100 μl of media
was removed and added to a 96-well assay plate (Corning Costar
Inc., Tewksbury MA, USA, Cat#3795) and absorbance read at
450 nm with background subtraction reading at 650 nm on an
Biotek Epoch plate reader (BioTek Inc., Winooski, VT, USA).
2.6. Glutamine measurements
Glutamine levels were measured in cell culture media using an
immobilized enzyme electrode-based YSI 2950 Biochemistry
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normalized to levels in control medium not exposed to cells but
treated identically (to control for evaporation) and to cell number.
Cells numbers used matched those in the proliferation assay. Final
media volume was raised to 1 ml per manufacturer's requirements
for analysis on the bioanalyzer.
2.7. Statistical analysis
All statistical tests were two-tailed. All data were normally
distributed. Independent t-test was used to compare outcomes of
in vitro assays between mono- and co-culture arms and between
media and treatment arms. Delta CT values were compared for
statistical analysis of QRTPCR data. Error bars in ﬁgures are stan-
dard error of the mean.Fig. 1. Adipocytes promote PanIN and PDAC cell proliferation in a glutamine-dependent
3T3L1 adipocytes on standard plastic (left) and on a transwell insert (right). Bottom: Upre
on QRTPCR in mature 3T3L1 adipocytes relative to undifferentiated 3T3L1 preadipocyt
transcript levels in mature adipocytes relative to transcript levels in undifferentiated
adipocytes to undifferentiated 3T3L1 cell referent; n¼5 experiments. (B) PanIN/PDAC
culture for 72 h in low serum (0.5%FCS) glutamine-free media with the indicated glucos
concentration (right). Ordinates: percent change in XTT signal relative to PanIN/PDAC cell
set at zero; *: po0.050 comparing experimental condition to referent PanIN/PDAC cell p
are maintained in nutrient-poor media: PanIN/PDAC cell proliferation in monoculture for
Ordinates: percent change in XTT signal relative to PanIN/PDAC cells in monoculture at
comparing experimental condition to referent time-zero PanIN/PDAC cell proliferation n
proliferation after 72 h in low serum media with the indicated glucose and glutamine
differentiated adipocytes (Ad CC); mature adipocyte-conditioned media (Ad CM); or un
relative to PanIN/PDAC cells in monoculture in the same substrate conditions indicated i
referent PanIN/PDAC cell proliferation n¼6 experiments. (E) Adipocytes rescue PDAC cell
72 h culture in low serum glucose-free media and (left to right): monoculture with 4 mM
(Ad CC, Gln 0 mM), co-culture with mature adipocytes pre-treated for 24 h with L-me
adipocytes and GPNA with 0 mM glutamine (Ad CC, GPNA, Gln 0 mM), or monoculture w
XTT signal in experimental arm relative to PanIN/PDAC cells in monoculture in low se
experimental condition to referent PanIN/PDAC cell proliferation n¼7 experiments.3. Results
3.1. PanIN and PDAC cell proliferation is glutamine-dependent
3T3L1 adipocytes accumulate cytoplasmic lipid and up-regulate
adipogenic genes (Fig. 1A), and maintain 490% viability over 5–7
days in in vitro culture based on Trypan Blue staining (data not
shown). We conﬁrmed glutamine dependency of PanIN and PDAC
cell (PI34 and PD7591 respectively) proliferation in monoculture
in DMEM/0.5% FCS with 0 mM glutamine and variable glucose
concentrations, or 0 mM glucose and variable glutamine con-
centrations, followed by XTT assay. Time-course experiments de-
monstrated peak proliferation at 72 h, the time-point used for
subsequent experiments. In the absence of glutamine with glucose
present, PanIN/PDAC cell proliferation was low, similar tomanner: (A) 3T3L1 adipocytes: Top: Photomicrograph of Oil Red-O-stained mature
gulation of adipogenic gene transcripts (PPAR-γ, FASN, ATGL, SREBP1c, CEBP-α) based
es cultured on standard plastic or on a transwell insert. Ordinate: fold increase in
3T3L1 cells as a referent¼1; *: po0.001 comparing transcript levels in mature
cell proliferation is glutamine-dependent: PanIN/PDAC cell proliferation in mono-
e concentration (left), or in glucose-free media with the indicated glutamine (Gln)
s in monoculture in nutrient-poor (glucose-free, glutamine-free) media as a referent
roliferation n¼6 experiments. (C) Positive PanIN/PDAC cell proliferation trajectories
72 h in low serum media with the indicated glucose and glutamine concentrations.
time-zero in the corresponding culture conditions as a referent¼zero; *: po0.050
¼7 experiments. (D) Adipocytes promote PDAC cell proliferation: PanIN/PDAC cell
concentrations with one of the following in an overlying transwell insert: mature
differentiated pre-adipocytes (Undiff CC). Ordinates: percent increase in XTT signal
n each graph as a referent¼zero; *: po0.050 comparing experimental condition to
proliferation in a glutamine-dependent manner: PanIN/PDAC cell proliferation after
glutamine (MC, Gln 4 mM), co-culture with mature adipocytes in 0 mM glutamine
thionine sulfoximine in 0 mM glutamine (Ad CC/GSI, Gln 0 mM), co-culture with
ith GPNA in 4 mM glutamine (MC, GPNA, Gln 4 mM). Ordinate: percent change in
rum glucose-free, glutamine-free media as a referent¼0; *: po0.050 comparing
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glutamine, 0.5% FCS as sole energy source); in the absence of
glucose, in contrast, glutamine rescued PanIN/PDAC cell pro-
liferation at levels as low as 0.05–0.1 mM (Fig. 1B). Time-course
experiments conﬁrmed a positive proliferative trajectory in nu-
trient-poor media, albeit at lower levels than in nutrient-rich
media (Fig. 1C). Glutamine concentration in cell-free nutrient-poor
media (DMEM, 0.5% FCS, 0 mM glucose, 0 mM glutamine) mea-
sured with a YSI bioanalyzer was o0.01 mM, demonstrating that
0.5% FCS is not a signiﬁcant source of glutamine.
3.2. Adipocytes promote PanIN and PDAC cell proliferation
We studied the effect of undifferentiated 3T3L1 preadipocytes,
mature 3T3L1 adipocytes, and 3T3L1 adipocyte-conditioned media
on PanIN/PDAC cell proliferation in variable substrate conditions.
Preadipocytes, adipocytes, and adipocyte-conditioned media in-
duced modest PanIN/PDAC cell proliferation in nutrient-rich
media. This effect of adipocytes and adipocyte-conditioned media
(but not preadipocytes) was signiﬁcantly ampliﬁed in nutrient-
poor media (Fig. 1D). These data demonstrate that while both
preadipocytes and adipocytes promote modest PanIN/PDAC cell
proliferation in nutrient-rich conditions, adipocytes predominate
in nutrient-poor conditions.Fig. 2. Adipocytes secrete glutamine and PDAC cells regulate adipocyte glutamine meta
glucose-free, glutamine-free media at 72 h with a YSI Bioanalyzer in: preadipocyte
monocultures (PI34 MC, PD7591 MC), mature adipocyte monocultures with PI34 or PD
adipocyte monocultures with L-methionine sulfoximine and 0 mM glutamine (Ad MCþ
comparing glutamine levels in mature adipocyte monoculture to preadipocyte monocu
expression in adipocytes: Left: Adipocyte metabolic enzyme expression in response to Pa
Western blots of protein lysates from adipocytes cultured with PDAC cells in low serum
culture in identical media as a referent¼zero probed with antibodies to glutamine synth
to actin densitometry. *: po0.050 for densitometry reading comparing adipocytes in P
Representative Western blot of protein lysates from adipocytes in monoculture (Ad) or i
regulation of adipocyte glutamine metabolism to promote glutamine shuttling: Inhibitio
adipocytes (red arrow), predisposing to glutamine secretion (green arrow).3.3. Adipocyte-induced PDAC cell proliferation is glutamine-
dependent
We studied the role of glutamine in adipocyte-induced PanIN/
PDAC cell proliferation in nutrient-poor conditions using L-me-
thionine sulfoximine, an irreversible inhibitor of glutamine syn-
thetase, or GPNA, an inhibitor of cellular glutamine export. PDAC
cells in monoculture in DMEM/0.5%FCS/0 mM glucose/4 mM glu-
tamine were studied as a positive control. Adipocytes rescued
PanIN/PDAC cell proliferation in the absence of glutamine to a
signiﬁcantly greater degree than preadipocytes. Inhibition of adi-
pocyte glutamine synthetase with L-methionine sulfoximine ab-
rogated adipocyte-induced PanIN/PDAC cell proliferation in the
absence of glutamine, as did inhibition of glutamine export with
GPNA (Fig. 1E). These data demonstrate that adipocyte-induced
PanIN/PDAC cell proliferation is glutamine-dependent, and that
inhibition of glutamine synthetase or glutamine exporter function
in adipocytes abrogates adipocyte-mediated rescue of PDAC cell
proliferation in the absence of glutamine.
3.4. Adipocytes secrete glutamine; PDAC cells down-regulate adipo-
cyte glutaminase expression
We conﬁrmed glutamine secretion by adipocytes by directly
measuring glutamine with a YSI bioanalyzer. Adipocytes in DMEM/bolism: (A) 3T3L1 adipocytes secrete glutamine: Glutamine secretion in low serum
and mature adipocyte monocultures (Undiff MC, Ad MC), PI34 and PD7591 cell
7591 cell-conditioned media (Ad MCþPI34 CM, Ad MCþPD7591 CM), and mature
GSI). Ordinate: glutamine concentration (mM) in culture supernatant; *: po0.050
lture (Undiff MC); n¼16 experiments. (B) PDAC cells down-regulate glutaminase
nIN/PDAC cell co-culture; ordinate: % change in ﬂuorescent intensity readings from
glucose-free, glutamine-free media, relative to lysates from adipocytes in mono-
etase (GS), glutaminase (GLS), or glutamate dehydrogenase (GDH), and normalized
anIN/PDAC cell co-culture to adipocytes in monoculture; n¼6 experiments. Right:
n co-culture with indicated PanIN/PDAC cell line. (C) Model for PDAC cell-mediated
n of glutaminase (GLS) in adipocytes by PDAC cells inhibits glutamine catabolism by
K.A. Meyer et al. / Biochemistry and Biophysics Reports 7 (2016) 144–1491480.5%FCS/0 mM glucose/0 mM glutamine secreted glutamine at le-
vels of 0.2 mM; preadipocytes secreted nominal levels of glu-
tamine in identical culture conditions; a trend towards modest
increased glutamine secretion by mature adipocytes was observed
in response to culture with PanIN/PDAC cell-conditioned media
(Fig. 2A). To determine if PDAC cells regulate adipocyte glutamine
metabolism, we studied adipocyte expression of glutamine-related
enzymes in response to PanIN/PDAC co-culture with Western
blotting. Relative to adipocytes in monoculture, glutaminase ex-
pression was reduced in adipocytes co-cultured with PDAC cells,
but not PanIN cells. Adipocyte glutamine synthetase or glutamate
dehydrogenase expression was not regulated by PanIN or PDAC
cells (Fig. 2B).4. Discussion
Adipocytes promote in vitro and in vivo progression of multiple
cancers [3,7,10,24]. Only a few studies implicate adipocytes in
PDAC [11,13,15]. Our data add to this sparse literature. PanIN/PDAC
cell proliferation was glutamine-dependent in the murine cell
lines we studied, observations that led us to explore whether
adipocytes promoted proliferation in the cells and whether glu-
tamine transfer contributed to this effect. We demonstrate that
3T3L1 adipocytes promote murine PanIN and PDAC cell prolifera-
tion in nutrient-poor conditions via glutamine shuttling. Adipo-
cytes promoted modest PanIN/PDAC cell proliferation in nutrient-
rich conditions, but this effect was markedly ampliﬁed in nutrient-
poor conditions, simulated in these experiments with low serum
(0.5%FCS), 0 mM glucose, 0 mM glutamine media. While in vitro
culture does not perfectly model in vivo conditions, the in vivo
PDAC tumor microenvironment has been shown to be character-
ized by low energy substrate availability [25], and we demonstrate
positive proliferation trajectories of PanIN/PDAC cells in nutrient-
poor media. Taken together these observations suggest that the
effects we observed in the nutrient-poor culture conditions we
studied are clinically relevant, and that adipocytes act as an energy
source for PDAC cells primarily in conditions of nutrient scarcity.
Of interest, proliferation in the PI34 and PD7591 cell lines was
glutamine-dependent but not glucose dependent, suggesting that
glutamine plays a more important role than glucose in prolifera-
tion of PanIN and PDAC cells in such conditions. Identiﬁcation of
the source of glutamine secreted by adipocytes will require further
study, but glutamine may derive from catabolism of lipid stores, an
explanation consistent with the observed secretion of glutamine
by adipocytes but not preadipocytes, the latter lacking substantial
lipid stores.
Adipocyte co-culture promoted PanIN/PDAC proliferation to a
greater extent than adipocyte-conditioned media, suggesting that
reciprocal crosstalk underlies at least some of the proliferative
effects of adipocytes. Prostate and breast cancer cells regulate ﬁ-
broblast lactate exporter expression to promote lactate shuttling
[26]. Reciprocal regulation of lipid metabolism promotes fatty acid
shuttling between adipocytes and ovarian cancer cells [8]. Fibro-
blasts and breast cancer cells engage in glutamine shuttling [20],
and a single report demonstrates glutamine shuttling between
adipocytes and leukemia cells via regulation of adipocyte gluta-
mine synthetase [21]. Glutamine is an important energy substrate
for PDAC [19]. We demonstrate that 3T3L1 adipocytes secrete
glutamine and that inhibition of glutamine cell export or gluta-
mine synthetase abrogates adipocyte-induced PanIN/PDAC cell
proliferation, conﬁrming glutamine as an underlying mediator of
this effect. Furthermore, PDAC cells decreased glutaminase ex-
pression in adipocytes, which would be expected to inhibit adi-
pocyte glutamine catabolism and increase glutamine secretion,
suggesting a mechanism of reciprocal crosstalk (Fig. 2C). No sucheffect was observed with PanIN cells, suggesting that PDAC inﬂu-
ences adipocyte glutamine metabolism to a greater degree than
PanIN, and that the growth-promoting effects of adipocytes on
PanIN cells, unlike PDAC cells, appear to be glutaminase-in-
dependent. Adipocytes constitutively secreted glutamine in
monoculture, suggesting that glutamine secretion is not com-
pletely dependent on regulation by PanIN or PDAC cells. Further-
more and of importance, adipocytes induced PDAC cell prolifera-
tion in glutamine-free conditions to a greater extent than in PDAC
cell monoculture in the presence of glutamine, suggesting that
mechanisms in addition to glutamine transfer underlie at least
some component of adipocyte-induced PDAC cell proliferation.
Further research will be required to elucidate such mechanisms,
which may include other nutrients, adipokines, and other adipo-
cyte-derived mediators. This focused study does not rule out
regulation of glutamine or other metabolic pathways at post-
translational or functional levels, nor does it rule out other energy
substrates (e.g. lipids) or mechanisms (e.g. adipokines) as media-
tors of adipocyte-PanIN/PDAC crosstalk, nor activation of oncogene
gene expression (for example glutamine-mediated activation of k-
Ras, for which precedent exists [27]), issues that will require fur-
ther research. Nonetheless, taken together, our observations sug-
gest that glutamine shuttling underlies adipocyte-induced PanIN/
PDAC cell proliferation in nutrient-poor conditions and that re-
ciprocal metabolic crosstalk contributes to this effect in adipocyte-
PDAC interactions, with down-regulation of adipocyte glutaminase
expression in response to PDAC cells.
Mature adipocytes, preadipocytes, or both promote breast, co-
lon, and prostate cancer cell proliferation [3,5,7,28,29]. A single
report demonstrates that human preadipocytes induce PDAC cell
proliferation; these investigators did not study mature adipocytes
[13]. We demonstrate that both 3T3L1 preadipocytes and mature
3T3L1 adipocytes promote modest PanIN/PDAC cell proliferation
in nutrient-rich media, but that proliferation in response to ma-
ture adipocytes but not preadipocytes increased signiﬁcantly in
nutrient-poor media. These ﬁndings suggest that nutrient transfer
underlies the proliferative effects of mature adipocytes in nu-
trient-poor conditions, but other mechanisms, including possible
preadipocyte effects, may be active in nutrient-rich conditions.
This is one of only a few reports demonstrating a role for adi-
pocytes in promoting PanIN/PDAC cell proliferation and the ﬁrst to
demonstrate glutamine shuttling between adipocytes and PanIN/
PDAC cells. These data suggest glutamine metabolism as a target
for further research into adipocyte-PDAC interactions.Funding
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